Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (271-280 of 337) with videos related to

Pageof 34
Sort By:
Journal of Clinical Pharmacology|September 1, 2009
The effect of raltegravir on the glucuronidation of lamotrigineMatthijs van Luin, Angela Colbers, Corrien P W G M Verwey-van Wissen, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2013
Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazoleClara T M M de Kanter, Angela P H Colbers, Maren I Blonk, et al.
AIDS (London, England)|February 3, 2022
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatmentLucas E Hermans, Laura M Hofstra, Rob Schuurman, et al.
Clinical Pharmacology and Therapeutics|August 8, 2006
Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjectsManon J van der Lee, Lara Dawood, Hadewych J M ter Hofstede, et al.
Therapeutic Drug Monitoring|January 28, 2003
Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrationsDavid M Burger, Patricia W H Hugen, Rob E Aarnoutse, et al.
Clinical Pharmacology and Therapeutics|September 18, 2018
Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis PatientsLindsey H M Te Brake, Vycke Yunivita, Resvi Livia, et al.
Annual Review of Pharmacology and Toxicology|July 19, 2017
The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black BoxLindsey H M Te Brake, Gerjo J de Knegt, Jurriaan E de Steenwinkel, et al.
Therapeutic Drug Monitoring|July 21, 2015
The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 ActivityMarieke E B Welzen, Vincent O Dezentjé, Ron H N van Schaik, et al.
British Journal of Clinical Pharmacology|May 6, 2017
Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteersElise J Smolders, Angela Colbers, Clara T M M de Kanter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2011
Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV preventionEva P Muro, Quirine Fillekes, Elton R Kisanga, et al.
Pageof 34

Showing results (271-280 of 337) with videos related to

Sort By:
Pageof 34
Journal of Clinical Pharmacology|September 1, 2009
The effect of raltegravir on the glucuronidation of lamotrigineMatthijs van Luin, Angela Colbers, Corrien P W G M Verwey-van Wissen, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2013
Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazoleClara T M M de Kanter, Angela P H Colbers, Maren I Blonk, et al.
AIDS (London, England)|February 3, 2022
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatmentLucas E Hermans, Laura M Hofstra, Rob Schuurman, et al.
Clinical Pharmacology and Therapeutics|August 8, 2006
Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjectsManon J van der Lee, Lara Dawood, Hadewych J M ter Hofstede, et al.
Therapeutic Drug Monitoring|January 28, 2003
Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrationsDavid M Burger, Patricia W H Hugen, Rob E Aarnoutse, et al.
Clinical Pharmacology and Therapeutics|September 18, 2018
Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis PatientsLindsey H M Te Brake, Vycke Yunivita, Resvi Livia, et al.
Annual Review of Pharmacology and Toxicology|July 19, 2017
The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black BoxLindsey H M Te Brake, Gerjo J de Knegt, Jurriaan E de Steenwinkel, et al.
Therapeutic Drug Monitoring|July 21, 2015
The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 ActivityMarieke E B Welzen, Vincent O Dezentjé, Ron H N van Schaik, et al.
British Journal of Clinical Pharmacology|May 6, 2017
Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteersElise J Smolders, Angela Colbers, Clara T M M de Kanter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2011
Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV preventionEva P Muro, Quirine Fillekes, Elton R Kisanga, et al.
Pageof 34